Interestingly, CYP17A1 knockdown abolished Sp1-enhanced invasiveness (Supplementary Figure S10D), thus further suggesting that Sp1-mediated CYP17A1 expression is required for glioma malignancy. The gene discussed is CYP17A1; the disease is glioma.